Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy

Current Hypertension Reviews

Volumn 10, Issue 1, 2014, Pages 41-48

  Ghembaza, M A ^a   Senoussaoui, Y ^a   Tani, M Kendouci ^a   Meguenni, K ^a  

^a Ctr Hosp Universitaire de Tlemcen   (Algeria)

Author keywords

Adherence; Comorbidities; Hypertension; Knowledge about hypertension complications; Measurement of adherence; Primary health care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ALGERIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE; ATTITUDE TO HEALTH; COMPLICATION; MEDICATION COMPLIANCE; PSYCHOLOGY;

ANTIHYPERTENSIVE AGENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MEDICATION ADHERENCE;

EID: 84926285397     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/157340211001141111160653     Document Type: Article

References (59)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335(8692): 765-74.
2. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138(3 Pt 2): 211-9.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-23.
4. Sadeghi M, Shiri M, Roohafza H, Rakhshani F, Sepanlou S, Sarrafzadegan N. Developing an appropriate model for self-care of hypertensive patients: first experience from EMRO. ARYA atherosclerosis. 2013; 9(4): 232-40.
5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-13.
6. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310(9): 959-68.
7. Lynch WD, Markosyan K, Melkonian AK, Pesa J, Kleinman NL. Effect of antihypertensive medication adherence among employees with hypertension. Am J Managed Care 2009; 15(12): 871-80.
8. Dragomir A, Cote R, Roy L, Blais L, Lalonde L, Berard A, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010; 48(5): 418-25.
9. Diamantopoulos EJ, Andreadis EA, Vassilopoulos CV, Giannakopoulos NS, Papadopoulou P, Tsourous GI, et al. Adherence to an intensive antihypertensive follow-up programme. J Human Hyperten 2003; 17(6): 437-9.
10. Sabatâe E. Adherence to long-term therapies: evidence for action: World Health Organization; 2003.
11. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med 2005; 353(5): 487-97.
12. Prado JC, Jr., Kupek E, Mion D, Jr. Validity of four indirect methods to measure adherence in primary care hypertensives. J Human Hyperten 2007; 21(7): 579-84.
13. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997; 35(11): 1164-70.
14. Hawkshead J, Krousel-Wood MA. Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings: Advantages and Limitations. Disease Management & Health Outcomes. 2007 //; 15(2): 109-18.
15. Nejjari C, Arharbi M, Chentir MT, Boujnah R, Kemmou O, Megdiche H, et al. Epidemiological Trial of Hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens 2013; 31(1): 49-62.
16. Latifa BH, Kaouel M.[Cardiovascular risk factors in Tlemcen (Algeria)]. Sante 2007; 17(3): 153-8.
17. Temmar M, Labat C, Benkhedda S, Charifi M, Thomas F, Bouafia MT, et al. Prevalence and determinants of hypertension in the Algerian Sahara. J Hypertens 2007; 25(11): 2218-26.
18. Girerd X, Radauceanu A, Achard JM, et al. Evaluation of patient compliance among hypertensive patients treated by specialists. Archives des maladies du coeur et des vaisseaux 2001; 94(8): 839-42.
19. Sackett DL, Haynes RB, Gibson ES, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975; 1(7918): 1205-7.
20. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004; 22(10):1849-55.
21. Hassan NB, Hasanah CI, Foong K, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Human Hypertens 2006; 20(1): 23-9.
22. Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens 2007; 9(3): 179-86.
23. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PloS one 2013; 8(4): e62775.
24. Keeley RD, Driscoll M. Effects of emotional response on adherence to antihypertensive medication and blood pressure improvement. Intern J Hyperten 2013; 2013: 358562.
25. Demoner MS, Ramos ERDP, Pereira ER. Factors associated with adherence to antihypertensive treatment in a primary care unit. Acta Paulista de Enfermagem 2012; 25: 27-34.
26. Ghozzi H, Kassis M, Hakim A, et al.[Medication adherence of a sample of hypertensive patients in the region of Sfax (Tunisia)]. Annales de cardiologie et d'angeiologie. 2010; 59(3): 131-7.
27. Ikama MS, Nsitou BM, Loumouamou M, Kimbally-Kaky G, Nkoua JL.[Drug compliance and its factors in a group of hypertensive Congolese]. Pan African Med J 2013; 15: 121.
28. Pio M, Baragou S, Afassinou Y, et al. Adherence to hypertension and its determinants in the cardiology department of the University Hospital of Lome Tokoin. Pan African Med J 2013; 14: 48.
29. Konin C, Adoh M, Coulibaly I, et al. Black Africans' compliance to antihypertensive treatment. Archives des maladies du coeur et des vaisseaux 2007; 100(8): 630-4.
30. Ambaw A, Alemie G. W/Yohannes S, Mengesha Z. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC public health 2012; 12(1): 282.
31. Youssef RM, Moubarak, II. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J 2002; 8(4-5): 579-92.
32. Hashmi SK, Afridi MB, Abbas K, et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PloS one 2007; 2(3): e280.
33. Santa Helena ET, Nemes MI, Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing nonadherence to medicines. Revista de saude publica 2008; 42(4): 764-7.
34. Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc 2012; 60(7):1298-303.
35. Wong MC, Jiang JY, Griffiths SM. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol 2010; 50(5): 598-605.
36. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a highrisk medicaid population. J Nat Med Assoc 2009; 101(1): 34-9.
37. Elliott WJ. Optimizing medication adherence in older persons with hypertension. Intern Urol Nephrol 2003; 35(4): 557-62.
38. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004; 164(7): 722-32.
39. Indian Polycap S, Yusuf S, Pais P, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009; 373(9672): 1341-51
40. Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. J Med Eco 2012; 15(1):155-65.
41. Dickson M, Plauschinat CA. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. American journal of cardiovascular drugs: drugs, devices, and other interventions 2008; 8(1): 45-50.
42. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congestive heart failure 2003; 9(6): 324-32.
43. Waeber B, Feihl F. The Relevance of Long-Term Adherence to Non-Pharmacological and Pharmacological Treatment of Hypertension. Curr Hypertens Rev 2007; 3(3): 203-7.
44. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Therap 2001; 23(8): 1296-310.
45. Sjolander M, Eriksson M, Glader EL. The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ open 2013; 3(9): e003551.
46. Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons for adherence with antihypertensive medication. Intern J Cardiol. 2000; 76(2-3): 157-63.
47. Karakurt P, Kasikci M. Factors affecting medication adherence in patients with hypertension. J Vascul Nursing 2012; 30(4): 118-26.
48. Maimaris W, Paty J, Perel P, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med 2013; 10(7): e1001490.
49. Vawter L, Tong X, Gemilyan M, Yoon PW. Barriers to antihypertensive medication adherence among adults--United States, 2005. J Clin Hyperten 2008; 10(12): 922-9.
50. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 1999; 160(1): 31-7.
51. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Pub Health 1996; 86(12): 1805-8.
52. Gryglewska B. How can we improve the effectiveness of treatment in elderly hypertensives? Blood Press 2005; 14(S2): 46-9.
53. Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hyperten 2009; 22(4): 392-6.
54. Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hyperten 2002; 16(8).
55. Ben Abdelaziz A, Ben Othman A, Mandhouj O, Gaha R, Daouas F, Ghannem H. The quality of first line management of arterial hypertension in the sanitary region of Sousse. Annales de cardiologie et d'angeiologie 2005; 54(5): 269-75.
56. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective casecontrol study. Bmj 2001; 21: 323(7305): 142-6.
57. Hasford J, Schroder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G. Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 2007; 63(11): 1055-61.
58. Wilinski J, Dabrowski M. Medication adherence in hypertensive patients of different cardiovascular risk treated in primary health care. Przeglad lekarski 2013; 70(6): 377-80.
59. Mulazzi I, Cambou JP, Girerd X, Nicodeme R, Chamontin B, Amar J. Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice. Journal of the American Society of Hypertension: JASH 2009; 3(3): 221-7.